• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的非人灵长类动物抗原图谱

Nonhuman primate antigenic cartography of SARS-CoV-2.

作者信息

Rössler Annika, Netzl Antonia, Lasrado Ninaad, Chaudhari Jayeshbhai, Mühlemann Barbara, Wilks Samuel H, Kimpel Janine, Smith Derek J, Barouch Dan H

机构信息

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Center for Pathogen Evolution, Department of Zoology, University of Cambridge, CB2 3EJ, Cambridge, Cambridgeshire, UK.

出版信息

Cell Rep. 2025 Jan 28;44(1):115140. doi: 10.1016/j.celrep.2024.115140. Epub 2025 Jan 3.

DOI:10.1016/j.celrep.2024.115140
PMID:39754717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11781863/
Abstract

Virus neutralization profiles against primary infection sera and corresponding antigenic cartography are integral part of the COVID-19 and influenza vaccine strain selection processes. Human single variant exposure sera have previously defined the antigenic relationships among SARS-CoV-2 variants but are now largely unavailable due to widespread population immunity. Therefore, antigenic characterization of future SARS-CoV-2 variants will require an animal model, analogous to using ferrets for influenza virus. We evaluated neutralization profiles against 23 SARS-CoV-2 variants in nonhuman primates (NHPs) after single variant exposure and generated an NHP-derived antigenic map. We identified a distant antigenic region occupied by BA.2.86, JN.1, and the descendants KP.2, KP.3, and KZ.1.1.1. We also found that the monovalent XBB.1.5 mRNA vaccine induced broad immunity against the mapped antigenic space. In addition, substantial concordance was observed between our NHP-derived and two human antigenic maps, demonstrating the utility of NHPs as a surrogate for antigenic cartography in humans.

摘要

针对初次感染血清的病毒中和谱以及相应的抗原图谱是新冠病毒和流感疫苗毒株选择过程的重要组成部分。人类单变体暴露血清此前已明确了新冠病毒变体之间的抗原关系,但由于人群普遍免疫,目前这类血清已基本无法获取。因此,未来对新冠病毒变体进行抗原特性分析将需要一种动物模型,类似于用雪貂研究流感病毒。我们评估了非人类灵长类动物(NHP)在暴露于单变体后针对23种新冠病毒变体的中和谱,并生成了一份源自NHP的抗原图谱。我们确定了一个由BA.2.86、JN.1及其后代KP.2、KP.3和KZ.1.1.1占据的远抗原区。我们还发现,单价XBB.1.5 mRNA疫苗诱导了针对所绘制抗原空间的广泛免疫。此外,我们源自NHP的抗原图谱与另外两份人类抗原图谱之间存在显著一致性,证明了NHP作为人类抗原图谱替代物的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/dd648aac4535/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/2c2eaa7dc5a5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/d8e1a4796772/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/e97bf864d6ef/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/7ad593b05041/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/e3bb5903233f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/dd648aac4535/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/2c2eaa7dc5a5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/d8e1a4796772/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/e97bf864d6ef/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/7ad593b05041/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/e3bb5903233f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a0/11781863/dd648aac4535/gr5.jpg

相似文献

1
Nonhuman primate antigenic cartography of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的非人灵长类动物抗原图谱
Cell Rep. 2025 Jan 28;44(1):115140. doi: 10.1016/j.celrep.2024.115140. Epub 2025 Jan 3.
2
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1.人类和仓鼠血清在鉴定 SARS-CoV-2 变体(包括 JN.1)中的抗原漂移方面具有良好的相关性。
J Virol. 2024 Nov 19;98(11):e0094824. doi: 10.1128/jvi.00948-24. Epub 2024 Oct 4.
3
Antigenic Cartography of SARS-CoV-2.SARS-CoV-2 抗原地图集
Biochemistry (Mosc). 2024 May;89(5):862-871. doi: 10.1134/S0006297924050079.
4
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections.多次接种新冠疫苗以及反复感染奥密克戎非 JN.1 或 JN.1 毒株后的奥密克戎亚变体中和作用及抗原图谱分析
Sci Rep. 2025 Jan 9;15(1):1454. doi: 10.1038/s41598-024-84138-0.
5
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies.XBB.1.5单价疫苗可诱导对SARS-CoV-2变体(如HV.1和JN.1)以及SARS-CoV-1产生持久的交叉反应,但产生的XBB.1.5特异性抗体有限。
mBio. 2025 Apr 9;16(4):e0360724. doi: 10.1128/mbio.03607-24. Epub 2025 Mar 5.
6
Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.新型冠状病毒XEC变异株N端结构域糖基化突变在免疫逃逸、细胞间融合及刺突蛋白稳定性中的作用
J Virol. 2025 Apr 15;99(4):e0024225. doi: 10.1128/jvi.00242-25. Epub 2025 Mar 26.
7
Continuous Tracking for Effective Tackling: Ad5/35 Platform-Based JN1 Lineage Vaccines Development in Response to Evolving SARS-CoV-2 Variants.持续追踪以有效应对:基于Ad5/35平台的JN1谱系疫苗研发以应对不断演变的SARS-CoV-2变体
J Med Virol. 2025 Feb;97(2):e70206. doi: 10.1002/jmv.70206.
8
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants.使用变异特异性仓鼠血清进行抗原作图显示,奥密克戎亚变体之间存在大量抗原变异。
Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2310917121. doi: 10.1073/pnas.2310917121. Epub 2024 Jul 30.
9
Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion.SARS-CoV-2 BA.2.87.1 和 JN.1 变体在免疫逃逸、抗原性和细胞间融合方面的独特模式。
mBio. 2024 May 8;15(5):e0075124. doi: 10.1128/mbio.00751-24. Epub 2024 Apr 9.
10
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.SARS-CoV-2 BA.4/5 感染在混合免疫背景下比 BA.1 引发更多的交叉反应性 FcγRIIIa 信号传导和中和作用。
J Virol. 2024 Jul 23;98(7):e0067824. doi: 10.1128/jvi.00678-24. Epub 2024 Jul 2.

引用本文的文献

1
Coordinated early immune response in the lungs is required for effective control of SARS-CoV-2 replication.肺部协调的早期免疫反应是有效控制SARS-CoV-2复制所必需的。
Nat Commun. 2025 Jun 25;16(1):5390. doi: 10.1038/s41467-025-60885-0.
2
Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.新型冠状病毒XEC变异株N端结构域糖基化突变在免疫逃逸、细胞间融合及刺突蛋白稳定性中的作用
J Virol. 2025 Apr 15;99(4):e0024225. doi: 10.1128/jvi.00242-25. Epub 2025 Mar 26.

本文引用的文献

1
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1.人类和仓鼠血清在鉴定 SARS-CoV-2 变体(包括 JN.1)中的抗原漂移方面具有良好的相关性。
J Virol. 2024 Nov 19;98(11):e0094824. doi: 10.1128/jvi.00948-24. Epub 2024 Oct 4.
2
Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination.新型冠状病毒奥密克戎 JN.1 变异株 mRNA 疫苗接种后的体液免疫
Lancet Infect Dis. 2024 Nov;24(11):e674-e676. doi: 10.1016/S1473-3099(24)00603-0. Epub 2024 Sep 25.
3
Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants.
JN.1 衍生的 SARS-CoV-2 SLip、FLiRT 和 KP.2 变体的中和逃逸、感染性和膜融合。
Cell Rep. 2024 Aug 27;43(8):114520. doi: 10.1016/j.celrep.2024.114520. Epub 2024 Jul 17.
4
Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)KP.3、LB.1和KP.2.3变体的病毒学特征
Lancet Infect Dis. 2024 Aug;24(8):e482-e483. doi: 10.1016/S1473-3099(24)00415-8. Epub 2024 Jun 27.
5
Virological characteristics of the SARS-CoV-2 KP.2 variant.严重急性呼吸综合征冠状病毒2型KP.2变体的病毒学特征。
Lancet Infect Dis. 2024 Jul;24(7):e416. doi: 10.1016/S1473-3099(24)00298-6. Epub 2024 May 20.
6
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.人血清和仓鼠血清中新冠病毒变异株特异性中和抗体的直接比较。
NPJ Vaccines. 2024 May 18;9(1):85. doi: 10.1038/s41541-024-00888-y.
7
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines.武汉-1 mRNA 疫苗对血清中和抗体的印迹作用。
Nature. 2024 Jun;630(8018):950-960. doi: 10.1038/s41586-024-07539-1. Epub 2024 May 15.
8
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.SARS-CoV-2 中和滴度的比较分析显示,人血清和动物模型血清以及不同检测之间具有一致性。
Sci Transl Med. 2024 May 15;16(747):eadl1722. doi: 10.1126/scitranslmed.adl1722.
9
High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays.高敏核衣壳蛋白检测方法显示先前严重急性呼吸综合征冠状病毒 2 感染的高频率。
J Infect Dis. 2024 Sep 23;230(3):e601-e604. doi: 10.1093/infdis/jiae174.
10
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans.接种 COVID-19 XBB.1.5 mRNA 加强针后,人体会持续产生免疫印记。
Immunity. 2024 Apr 9;57(4):904-911.e4. doi: 10.1016/j.immuni.2024.02.016. Epub 2024 Mar 14.